Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017095191) PHARMACEUTICAL COMPOSITION COMPRISING IMMUNOGLOBULIN FC-FUSED INTERLEUKIN-7 FUSION PROTEIN FOR PREVENTING OR TREATING HUMAN PAPILLOMAVIRUS-CAUSED DISEASES
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2017/095191 International Application No.: PCT/KR2016/014127
Publication Date: 08.06.2017 International Filing Date: 02.12.2016
IPC:
A61K 38/20 (2006.01) ,A61K 38/17 (2006.01) ,A61K 9/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
19
Cytokines; Lymphokines; Interferons
20
Interleukins
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
Applicants:
주식회사 제넥신 GENEXINE, INC. [KR/KR]; 경기도 성남시 분당구 대왕판교로 700 B동 4층 4F, Bldg. B, 700, Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do 13488, KR
Inventors:
강문철 KANG, Moon Cheol; KR
최영우 CHOI, Young Woo; KR
최동훈 CHOI, Donghoon; KR
성영철 SUNG, Young Chul; KR
Agent:
제일특허법인 FIRSTLAW P.C.; 서울시 서초구 마방로 60 60 Mabang-Ro, Seocho-Ku, Seoul 06775, KR
Priority Data:
62/263,26204.12.2015US
62/360,69611.07.2016US
62/361,17012.07.2016US
Title (EN) PHARMACEUTICAL COMPOSITION COMPRISING IMMUNOGLOBULIN FC-FUSED INTERLEUKIN-7 FUSION PROTEIN FOR PREVENTING OR TREATING HUMAN PAPILLOMAVIRUS-CAUSED DISEASES
(FR) COMPOSITION PHARMACEUTIQUE COMPRENANT UNE PROTÉINE DE FUSION D’INTERLEUKINE 7 FUSIONNÉS AVEC FC D’IMMUNOGLOBULINE POUR LA PRÉVENTION OU LE TRAITEMENT DE MALADIES CAUSÉES PAR LE PAPILLOMAVIRUS HUMAIN
(KO) 면역글로불린 FC가 융합된 인터루킨-7 융합 단백질을 포함하는 사람 파필로마바이러스 유래 질환의 예방 또는 치료용 약학적 조성물
Abstract:
(EN) The present invention relates to a pharmaceutical composition comprising an immunoglobulin Fc region and an IL-7 fusion protein. Specifically, when a fusion protein comprising the immunoglobulin Fc region and IL-7 is administered to an affected area, a strong immune response is induced in the body and thus allows human papillomavirus-caused diseases to be prevented or treated.
(FR) La présente invention concerne une composition pharmaceutique comprenant une région Fc d’immunoglobuline et une protéine de fusion d’IL-7. Spécifiquement, lorsqu’une protéine de fusion comprenant la région Fc d’immunoglobuline et IL-7 est administrée à une zone affectée, une réponse immunitaire forte est induite dans le corps et permet ainsi de prévenir ou traiter des maladies causées par le papillomavirus humain.
(KO) 본 발명은 면역글로불린 Fc 영역 및 IL-7 융합단백질을 포함하는 약학적 조성물에 관한 것으로, 구체적으로 상기 면역글로불린 Fc 영역 및 IL-7을 포함하는 융합단백질을 국소 투여할 경우 신체 내에 강한 면역반응을 유도하여, 사람 파필로마바이러스 유래 질환을 예방 또는 치료할 수 있다.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Korean (KO)
Filing Language: Korean (KO)
Also published as:
CN108697765US20180319858